Skip to main content
SpringerLink
Log in

QbD Enabled Formulation Development of Nanoemulsion of Nimodipine for Improved Biopharmaceutical Performance

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

The objective of the current research is to formulate a nanoemulsion (NE) of nimodipine (ND) to improve its oral bioavailability and stability by adopting a scientific and systematic quality-by-design (QbD) approach.

Methods

Triacetin (oil), Cremophor RH40 (surfactant), and PEG600 (co-surfactant) were selected to formulate NE. Factors affecting critical quality attributes (CQA) were screened by Taguchi design followed by Box-Behnken design (BBD) enabled optimization. The optimized NE was further lyophilized with trehalose (cryoprotectant) to improve the storage stability.

Results

Optimized NE (F4), and its lyophilized NE showed globule size less than 200 nm with more than 75% drug diffusion within 30 min. Both NE (F4) and its lyophilized NE exhibited a fivefold increase in area under the curve in comparison to an aqueous dispersion of ND. Lyophilized F4 showed better stability due to the conversion of NE into solid form by lyophilization.

Conclusion

Lyophilized NE of ND can be prepared for improved oral bioavailability and stability. The above approach is simple, cost-effective, and scalable to manufacture on a commercial scale.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Data Availability

All data pertaining to this research will be made available.

References

  1. Inzitari DPA. Calcium channel blockers and stroke. Aging Clin Exp Res. 2005;17:16–30.

    PubMed  Google Scholar 

  2. Fu Q, Sun J, Ai X, et al. Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption. Int J Pharm. 2013;448:290–7.

    Article  CAS  PubMed  Google Scholar 

  3. Luo JW, Zhang ZR, Gong T, et al. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine. Int J Nanomedicine. 2016;11:1051–65.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10:69–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cj P, Nl T, Wn C. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231–48.

    Article  Google Scholar 

  6. Chhabra G, Chuttani K, Mishra AK, et al. Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev Ind Pharm. 2011;37:907–16.

    Article  CAS  PubMed  Google Scholar 

  7. Veerareddy PR, Poluri K, Sistla R. Formulation development and comparative pharmacokinetic evaluation of felodipine nanoemulsions in SD rats. Am J PharmTech Res. 2012;2:931–945.

  8. Khani S, Keyhanfar F, Amani A. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Deliv. 2016;23:2035–43.

    Article  CAS  PubMed  Google Scholar 

  9. Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2015;5:123–7.

    Article  PubMed  Google Scholar 

  10. Shekhawat P, Pokharkar V. Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: in-vitro characterization, PAMPA and in-vivo assessment. Int J Pharm. 2019. https://doi.org/10.1016/j.ijpharm.2019.06.006.

    Article  PubMed  Google Scholar 

  11. Panigrahi KC, Jena J, Jena GK, et al. QBD-based systematic development of Bosentan SNEDDS: formulation, characterization and pharmacokinetic assessment. J Drug Deliv Sci Technol. 2018;47:31–42.

    Article  CAS  Google Scholar 

  12. Sun Y, Rui Y, Wenliang Z, et al. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm. 2008;359:144–9.

    Article  CAS  PubMed  Google Scholar 

  13. Chudasama A, Patel V, Nivsarkar M, et al. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations. Drug Deliv. 2015;22:531–40.

    Article  CAS  PubMed  Google Scholar 

  14. Kassem AA, Mohsen AM, Ahmed RS, et al. Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, in vitro and in vivo evaluation. J Mol Liq. 2016;218:219–32.

    Article  CAS  Google Scholar 

  15. Routray SB, Patra CN, Raju R, et al. Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study. Drug Dev Ind Pharm. 2020;46:1080–91.

    Article  CAS  PubMed  Google Scholar 

  16. Czajkowska-Kos̈nik A, Szekalska M, Amelian A, et al. Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin. Molecules. 2015;20. https://doi.org/10.3390/molecules201219745.

  17. Inugala S, Eedara BB, Sunkavalli S, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation. Eur J Pharm Sci. 2015;74:1–10.

    Article  CAS  PubMed  Google Scholar 

  18. Sharma P, Singh SK, Pandey NK, et al. Impact of solid carriers and spray drying on pre/post-compression properties, dissolution rate and bioavailability of solid self-nanoemulsifying drug delivery system loaded with simvastatin. Powder Technol. 2018;338:836–46.

    Article  CAS  Google Scholar 

  19. Gurumukhi VC, Bari SB. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies. Drug Deliv Transl Res. 2021;2021:1–21.

    Google Scholar 

  20. Arsiccio A, Pisano R. Application of the quality by design approach to the freezing step of freeze-drying: building the design space. J Pharm Sci. 2018. https://doi.org/10.1016/j.xphs.2018.02.003.

    Article  PubMed  Google Scholar 

  21. Laxmi M, Bhardwaj A, Mehta S, et al. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif Cells, Nanomedicine Biotechnol. 2015;43:334–44.

    Article  CAS  Google Scholar 

  22. Srinivas NSK, Verma R, Kulyadi GP, et al. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomedicine. 2017;12:15–28.

    Article  CAS  Google Scholar 

  23. Parmar N, Singla N, Amin S, et al. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surfaces B Biointerfaces. 2011;86:327–38.

    Article  CAS  PubMed  Google Scholar 

  24. Ujhelyi Z, Vecsernyés M, Fehér P, et al. Physico-chemical characterization of self-emulsifying drug delivery systems. Drug Discov Today Technol. 2018;27:81–6.

    Article  PubMed  Google Scholar 

  25. Xue X, Cao M, Ren L, et al. Preparation and optimization of rivaroxaban by self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability and no food effect. AAPS PharmSciTech. 2018. https://doi.org/10.1208/s12249-018-0991-6.

    Article  PubMed  Google Scholar 

  26. AboulFotouh K, Allam AA, El-Badry M, et al. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil. Eur J Pharm Sci. 2017;109:503–13.

    Article  CAS  PubMed  Google Scholar 

  27. Park SJ, Choo GH, Hwang SJ, et al. Quality by design: Screening of critical variables and formulation optimization of Eudragit e nanoparticles containing dutasteride. Arch Pharm Res. 2013;36:593–601.

    Article  CAS  PubMed  Google Scholar 

  28. Yasir M, Sara UVS, Chauhan I, et al. Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box-Behnken design, in vitro and in vivo evaluation. Artif Cells, Nanomedicine Biotechnol. 2018;46:1838–51.

    CAS  Google Scholar 

  29. Gade MM, Hurkadale PJ. Formulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: factorial design approach. Drug Deliv Transl Res. 2016. https://doi.org/10.1007/s13346-016-0289-8.

    Article  PubMed  Google Scholar 

  30. Patel P, Pailla SR, Rangaraj N, et al. Quality by design approach for developing lipid-based nanoformulations of gliclazide to improve oral bioavailability and anti-diabetic activity. AAPS PharmSciTech. 2019. https://doi.org/10.1208/s12249-018-1214-x.

    Article  PubMed  Google Scholar 

  31. Zhang JQ, Liu J, Li XL, et al. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 2007;14:381–7.

    Article  PubMed  Google Scholar 

  32. Kasongo KW, Pardeike J, Müller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100:5185–96.

    Article  CAS  PubMed  Google Scholar 

  33. Aa K, Vb P. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech. 2008;9:191–6.

    Article  Google Scholar 

  34. Panigrahi KC, Patra CN, Rao MEB. Quality by design enabled development of oral self-nanoemulsifying drug delivery system of a novel calcimimetic cinacalcet HCl using a porous carrier: in vitro and in vivo characterisation. AAPS PharmSciTech. 2019. https://doi.org/10.1208/s12249-019-1411-2.

    Article  PubMed  Google Scholar 

  35. Jena GK, Patra CN, Panigrahi KC, et al. QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of capecitabine for antitumor activity. Drug Deliv Transl Res. 2021. https://doi.org/10.1007/S13346-021-01042-0.

    Article  PubMed  Google Scholar 

  36. Quality Guidelines : ICH. 2018. http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html. Accessed 26 Dec 2018.

  37. Tartaro G, Mateos H, Schirone D, et al. Microemulsion microstructure(s): a tutorial review. Nanomater (Basel, Switzerland). 2020;10:1–40.

    Google Scholar 

  38. Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013;2013:1–16.

    Google Scholar 

Download references

Acknowledgements

The authors would like thank Dr. Sukant Tripathy, Professor, Berhampur University, India for providing facility for XRD study.

Author information

Authors and Affiliations

  1. Roland Institute of Pharmaceutical Sciences, Berhampur, Odisha, India

    Ch. Niranjan Patra, Archana Mishra, Goutam Kumar Jena, Kahnu Charan Panigrahi, Jammula Sruti, Debashish Ghose & Laxmidhar Sahoo

Authors
  1. Ch. Niranjan Patra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Archana Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Goutam Kumar Jena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kahnu Charan Panigrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jammula Sruti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Debashish Ghose
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Laxmidhar Sahoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed for this research manuscript.

Corresponding author

Correspondence to Ch. Niranjan Patra.

Ethics declarations

Ethics Approval

This research is approved by Institutional Anima Ethical Committee (IAEC) of Roland Institute of Pharmaceutical Sciences, Berhampur, with the following approval number 103 (Regd.No.926/PO/ac/06/CPCSEA).

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patra, C.N., Mishra, A., Jena, G.K. et al. QbD Enabled Formulation Development of Nanoemulsion of Nimodipine for Improved Biopharmaceutical Performance. J Pharm Innov 18, 1279–1297 (2023). https://doi.org/10.1007/s12247-023-09714-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-023-09714-9

Keywords

Search

Navigation